FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications

Article Link: FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications

South San Francisco, CA — April 12, 2021 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License…

Source: FDA New Drug Approvals